PLASMA ANTIPYRINE HALF-LIFE CAN BE DETERMINED FROM URINE DATA

被引:4
作者
ATIBA, JO
TAYLOR, G
PERSHE, RA
BLASCHKE, TF
机构
[1] STANFORD UNIV, MED CTR, SCH MED, DEPT MED, DIV CLIN PHARMACOL, STANFORD, CA 94305 USA
[2] UWIST, WELSH SCH PHARM, CARDIFF, WALES
关键词
D O I
10.1111/j.1365-2125.1987.tb03106.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:715 / 719
页数:5
相关论文
共 11 条
[1]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223
[2]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J].
DANHOF, M ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :529-537
[3]   ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :317-321
[4]   ASSESSMENT OF ANTIPYRINE KINETICS BY MEASUREMENT IN SALIVA [J].
FRASER, HS ;
MUCKLOW, JC ;
MURRAY, S ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :321-325
[5]  
SHEINER LB, 1981, PROGRAM EXTENDED LEA
[6]   FURTHER OBSERVATIONS ON RELATIONSHIPS BETWEEN ANTIPYRINE HALF-LIFE, CLEARANCE AND VOLUME OF DISTRIBUTION - AN APPRAISAL OF ALTERNATIVE KINETIC-PARAMETERS USED TO ASSESS THE ELIMINATION OF ANTIPYRINE [J].
SULTATOS, LG ;
DVORCHIK, BH ;
VESELL, ES ;
SHAND, DG ;
BRANCH, RA .
CLINICAL PHARMACOKINETICS, 1980, 5 (03) :263-273
[7]   MEASUREMENT OF ANTIPYRINE HALF-LIFE FROM URINARY DRUG CONCENTRATIONS [J].
TAYLOR, G ;
BLASCHKE, TF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) :650-652
[8]   DIFFERENTIAL INDUCTION OF ANTIPYRINE METABOLISM BY RIFAMPICIN [J].
TOVERUD, EL ;
BOOBIS, AR ;
BRODIE, MJ ;
MURRAY, S ;
BENNETT, PN ;
WHITMARSH, V ;
DAVIES, DS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :155-160
[9]  
VESELL ES, 1975, CLIN PHARMACOL THER, V18, P259
[10]   ASSESSMENT OF METHODS TO IDENTIFY SOURCES OF INTERINDIVIDUAL PHARMACOKINETIC VARIATIONS [J].
VESELL, ES ;
PENNO, MB .
CLINICAL PHARMACOKINETICS, 1983, 8 (05) :378-409